Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Exclusives

Exclusives

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Cannabis
  • Entrepreneurship
  • ESG
  • Events
  • Exclusives
  • General
  • Markets
  • News
  • Small Business
  • Startups
  • Success Stories

How To Align Medical Marijuana Strains With Specific Conditions: Learn From Dr. Chanda Macias, Scientist, Researcher And Cannabis Pioneer

By Maureen Meehan
July 24, 1:00 PM
Dr. Chanda Macias is a trailblazer in the legal cannabis industry many times over.

CL

Read More
2 minute read
  • Exclusives
  • News
  • Penny Stocks
  • Tech

EXCLUSIVE: Nisun Collaborates With Pinhutang Distillery To Boost China’s Agricultural Practices

By Anusuya Lahiri
July 22, 7:31 AM
NiSun Intl Enterprise Development Group Co, Ltd (NASDAQ: NISN) affiliate Fanlunke Supply Chain Management (Shanghai) Co, Ltd, a subsidiary of Fintech (Shanghai) Digital Technology Co, Ltd, forged a supply chain services agreement with Yunnan Pinh

BABA

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: HTG Molecular Diagnostics President & CEO, John Lubniewski Says Co Got Its First Drug Candidate In Development Right Now, Co Identified Its First Target, Says Co Expects To Have Its First Asset By The End Of The Year

By Benzinga Newsdesk
July 21, 11:10 AM
https://www.youtube.com/watch?v=GJEqcWyaaQs

HTGM

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: HTG Molecular Diagnostics President & CEO, John Lubniewski Now Interviewing On Benzinga’s Live YouTube TV

By Benzinga Newsdesk
July 21, 11:07 AM
Click To Tune In Here... https://www.youtube.com/watch?v=GJEqcWyaaQs

HTGM

Read More
4 minute read
  • Cannabis
  • Events
  • Exclusives
  • Markets
  • News

‘The Funny Thing Is That Cannabis Has Been In Every Social Circle I’ve Been A Part Of— And I Worked On Wall Street,’ Says Charlotte Hanna

By Nina Zdinjak
July 20, 2:58 PM
If you had one word to describe the marijuana industry, what would it be?  Perhaps, complex? 

GS

Read More
3 minute read
  • Cannabis
  • Events
  • Exclusives
  • Markets
  • News

The Secret Sauce Behind Successful Cannabis Investing: Meet Emily Paxhia Of Poseidon Asset Management

By Joana Scopel
July 20, 10:18 AM
Emily Paxhia, co-founder and managing partner at Poseidon Investment Management will be sharing her insights on managing cannabis investment funds, access to capital and investing in cannabis during at the upcoming Benzinga Cannabis

PSDN

Read More
2 minute read
  • Biotech
  • Exclusives
  • General
  • Health Care
  • News
  • Penny Stocks

EXCLUSIVE: Adial Pharma’s AD04 Effective In Heavy Drinker Alcohol Use Disorder Patients

By Vandana Singh
July 20, 6:45 AM
Adial Pharmaceuticals Inc's (NASDAQ: ADIL) ONWARD Phase 3 study of AD04 for Alcohol Use Disorder (AUD) achieved a statistically significant mean reduction in heavy drinking days compared to placebo.

ADIL

Read More
9 minute read
  • Exclusives
  • Market-Moving Exclusives
  • News

EXCLUSIVE: Adial Pharmaceuticals Announces Topline Results For ONWARD Phase 3 Trial For AD04 In Patients With Alcohol Use Disorder

By Benzinga Newsdesk
July 20, 6:45 AM
Charlottesville, VA – July 20, 2022 – Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing

ADIL

Read More
2 minute read
  • Exclusives
  • General
  • Markets
  • Media

EXCLUSIVE: Michelle Krebs Of Cox Automotive Says ‘If An Economic Recession Hits The US, Vehicle Sales Are Not Going To Be Affected Much’

By AJ Fabino
July 19, 12:32 PM
The average price of a new automobile sold in America in June was $48,043, according to Kelly Blue Book, a Cox Automotive company. This is the highest average price ever and the first time it has been above the $48,000 mark.

BAC

Read More
2 minute read
  • Cannabis
  • Events
  • Exclusives
  • Markets
  • News
  • Penny Stocks
  • Real Estate
  • REIT

Is Market Pressure Hindering Cannabis Real Estate Investment? Ask Rob Sechrist At The Cannabis Capital Conference In September

By Joana Scopel
July 18, 2:44 PM
Rob Sechrist, from what we've observed, loves talking about how market pressure - such as it is these shaky days - is not an obstacle for what he calls "the cannabis REIT parade."

JUVAF

Posts pagination

Previous 1 … 97 98 99 … 102 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service